key: cord-0890250-95gx4xo1
authors: Ghidini, Simone; Gasperetti, Alessio; Winterton, Dario; Vicenzi, Marco; Busana, Mattia; Pedrazzini, Giovanni; Biasco, Luigi; Tersalvi, Gregorio
title: Echocardiographic assessment of the right ventricle in COVID-19: a systematic review
date: 2021-07-22
journal: Int J Cardiovasc Imaging
DOI: 10.1007/s10554-021-02353-6
sha: de668f25e540ec49405d1bd7c9bc1806bb2c18e6
doc_id: 890250
cord_uid: 95gx4xo1

Cardiac involvement has been frequently reported in COVID-19 as responsible of increased morbidity and mortality. Given the importance of right heart function in acute and chronic respiratory diseases, its assessment in SARS-CoV-2 infected patients may add prognostic accuracy. Transthoracic echocardiography has been proposed to early predict myocardial injury and risk of death in hospitalized patients. This systematic review presents the up-to-date sum of literature regarding right ventricle ultrasound assessment. We evaluated commonly used echocardiographic parameters to assess RV function and discussed their relationship with pathophysiological mechanisms involved in COVID-19. We searched Medline and Embase for studies that used transthoracic echocardiography for right ventricle assessment in patients with COVID-19.

Coronavirus disease 2019 (COVID-19) is a systemic viral disease with predominantly respiratory clinical presentations leading to multi-organ complications and fatal outcomes. In particular, cardiac involvement and myocardial injury (defined as a rise in cardiac troponin) have been frequently reported as a consequence of COVID-19 [1, 2] and their presence is associated to increased morbidity and mortality [3, 4] .

Research efforts have focused on the identification of easy-to-use biological markers of myocardial injury with high predictive accuracy for in-hospital events [5] [6] [7] [8] . Despite those efforts, several pathophysiological mechanisms of cardiac involvement in COVID-19 are still ambiguous and need to be fully clarified. Preliminary data suggested that cardiac imaging studies can be useful as predictive tools, as well as to understand underlying mechanisms of cardiac involvement [9] [10] [11] [12] .

Given the clinical relevance of the right heart function in respiratory illness and acute respiratory distress syndrome Simone Ghidini and Alessio Gasperetti contributed equally as first authors to this work.

Luigi Biasco and Gregorio Tersalvi contributed equally as senior authors to this work.

(ARDS), [13] [14] [15] [16] transthoracic echocardiography (TTE) of the right ventricle (RV) may be crucial in evaluating patients with COVID-19, as suggested by European Association of Cardiovascular Imaging (EACVI) and American Society of Echocardiography (ASE) recommendations [17, 18] .

The aim of this systematic review is to summarize current knowledge on TTE-based RV assessment in COVID-19, focusing on the pathological mechanisms behind right chambers involvement, the parameters for prognostic assessment, and the clinical utility of TTE parameters in the trajectory of this disease.

This systematic review has been performed and reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [19] .

We conducted a comprehensive search of Medline (through PubMed) and Embase until April 30th, 2021. The following search terms were used:

(

After the primary search duplicates were removed. The obtained cohort were firstly screened by title by 2 independent reviewers (S.G, A.G.). Therefore, a subsequent control was performed through assessment of abstracts. All eligible studies were read in full, to control suitability for review inclusion. References of included manuscript were screened for the identification of potential additional studies of interest. Consensus of the 2 reviewers was needed for a study inclusion. A third reviewer (G.T.) served as final judge in cases of divergence between the 2 reviewers. 

Two independent investigators (S.G., A.G.) performed data extraction. To facilitate data extraction, a standardized extraction form was used, retrieving the following study characteristics: study design; number of patients enrolled; outcomes (defined as invasive mechanical ventilation [IMV], in-hospital death), and TTE parameters of interest (where available): left ventricular ejection fraction (LVEF) and global longitudinal strain (GLS) for Left Ventricle (LV); RV end diastolic diameter (RVEDD), RV end diastolic area (RVEDA) RV fractional area change (RVFAC), RV free wall longitudinal strain (RVLS), tricuspidal Anulus Plane Systolic Excursion (TAPSE), tricuspidal regurgitation peak velocity (TRV), tricuspid lateral annular systolic velocity (S'), pulmonary hypertension (PH), systolic pulmonary artery pressure (sPAP), inferior vena cava diameter and distensibility for RV.

The study selection process is presented in Fig. 1 . Out of a total of 795 initial results, 193 remained after removing duplicates, papers written in languages other than English, reviews, editorials, letters, and case reports. Of these, 78 were chosen based on title relevance for additional analysis of the abstracts, and 52 were designated for further analysis of the full text paper in which 7 works were excluded. Quality assessment did not reject any study. Fourty-five papers were therefore considered suitable for inclusion. No other published work was added after re-examining its reference lists. The systematic review finally included a total of 45 studies, which are presented in Table 1 .

Since RV size measurements are easy and quick to perform, many studies reported parameters of RV dilatation in COVID-19. The most frequent dimension reported is the RV end-diastolic diameter (RVEDD), measured at the RV base in apical 4-chamber projection [65] . It is demonstrated that RVEDD is increased in severe COVID-19 (as defined by the authors) [22, 23] , in subjects with myocardial injury [22] , and in those that did not survive to COVID-19 [48, 57] . In a small single-center study on patients without history of cardiovascular diseases (severe disease n = 40, severe disease excluding IMV n = 22), LV end diastolic diameter and other parameters of right heart involvement (i.e. right atrial area, RVFAC) were significantly different when comparing severe and milder COVID-19 patients, suggesting that these alterations are independent of ventilatory support [22] . Similar evidence in a comparison between ventilated and non-ventilated COVID-related ARDS is reported [45] .

Several studies assessed RV enlargement as a categorical variable with a binary cut-off of RVEDD, usually 41 mm, according to consensus guidelines. [65] Kim et al. [43] showed that RV dilatation defined as RVEDD > 41 mm was more frequent than RV systolic dysfunction (evaluated through TAPSE and S'), and patients with RV dilatation had higher rates of ARDS and IMV. Of interest, RV dilatation (and also RV dysfunction) were associated with LV dysfunction. Cardiac involvement in this setting could be considered a consequence of RV afterload increase mediated by the exacerbation of the systemic inflammation rather than of pulmonary disease alone [66] . Given the RV and LV interdependence and the prolonged exposure to higher filling pressures [67] , such critical systemic condition may influence hemodynamic and cause biventricular overload [48] .

Results from a prospective study enrolling 100 consecutive hospitalized patients with COVID-19 showed that RV dilatation (with or without dysfunction) was present in 39% of subjects within 24 h of admission, whilst LV diastolic and systolic dysfunction were less frequently observed (respectively 16% and 10%). [58] Compared to Kim et al. [43] , this study had a lower percentage of patients on IMV (10%), possibly suggesting a less severe setting of COVID-19. Furthermore, the definition of RV dilatation by Szelkey et al. [58] . is dependent on a bidimensional measurement (RVEDA). Nevertheless, in both cohorts, RV dilatation was associated with an increased risk of death.

Finally, abnormal RV size has been reported also at post-acute follow-up. A case-control study with 51 patients with COVID-19 patients recovering from the acute illness without need of IMV reported higher RVEDA compared to controls at one month from hospital discharge [39] . Similar results were obtained in another study with follow up at a median time of 133 ± 35 days [52] .

There is great heterogeneity in the medical literature on COVID-19 about RV systolic function evaluation. The most used parameters are TAPSE, RVFAC and S'. Frequently, multiparametric evaluations combining these three measurements are used.

TAPSE is reported to be lower in patients with cardiac wall motion abnormalities [56] and critical illness [22, 45] . It appears to be lower in patients at 30-day follow-up after hospital discharge for COVID-19 compared to healthy volunteers [39] and in subjects with fatal outcome [28, 32, 46-48, 50, 57] . Moreover, a prospective case-control study showed that TAPSE was decreased in COVID-19 patients compared to healthy matched patients and low values of TAPSE were found to be independent risk factors for COVID-related death [44] . Authors hypothesized that their findings might be attributable to direct cardiac involvement or a sign of systemic extension of the viral disease. TAPSE was a good predictor of mortality both in samples with low [46, 47] and high [48] rates of intubated patients and showed correlation with D-dimer and increased cardiac troponins [38, 50] .

Peak tricuspid annular longitudinal velocity (S′) is usually assessed as a categorical variable with a 9.5 cm cut-off for RV dysfunction. It is reported to be lower in patients with myocardial injury [33, 60] and at risk for in-hospital mortality [48] .

Similar to TAPSE and S′ wave, RVFAC appears to be lower in severe patients [22] , in subjects at 30-day followup [39] , and correlated to D-dimer [22, 49, 50] . If evaluated as a binary variable based on 35% cut-off for RV dysfunction, RVFAC has been shown to be predictive of mortality [47, 54] . Interestingly, in a study assessing RV dysfunction (TAPSE < 17 mm and/or RVFAC < 35%), RVFAC-based dysfunction was found to be more frequent than TAPSEbased dysfunction [49] , possibly explained by the marked reduction in radial RV systolic function but relative preservation of longitudinal shortening, as elucidated by another study [27] . The hypothesis is that TAPSE and S′ operate a compensatory response to radial dysfunction. Moreover, RV free wall longitudinal function can appear falsely preserved due to tethering to a normally functioning LV which has increased or preserved function.

Many studies report data about RV dysfunction using a combination of the presented parameters. The results are dependent on the disease severity of the sample. For example, in a population with a median ratio of arterial oxygen partial pressure to fractional inspired oxygen (Pa O2 /Fi O2 ) of 243, RV dysfunction (based on TAPSE and S′) was not associated with Pa O2 /Fi O2 and had no predictive power for mortality [53] . Conversely, RV dysfunction (based on TAPSE and RVFAC) was associated with Pa O2 /Fi O2 and all-cause mortality in samples with higher rate of IMV patients (mean Pa O2 /Fi O2 of 144) [50] . These results suggest that, during the initial stages of illness, TTE parameters of overt RV dysfunction may not be used as a valid predictor of mortality.

The correlation between troponin elevation and parameters of RV dysfunction has been evaluated [20, 22, 33, 47, 54] . A study including 305 subjects by Giustino et al. [37] identified myocardial injury as an independent risk factor for mortality, but only when major abnormalities were detected by TTE, particularly RV dysfunction (26.3%, determined by combination of visual assessment, TAPSE < 17 mm, S′ < 9.5 cm/s), LV wall motion abnormalities (23.7%), and LV global dysfunction (18.4%).

Several works hypothesized different mechanisms of SARS-CoV-2 myocardial injury [3, 4, 68] (Fig. 2) . The evidence of RV involvement presented in this review suggests that an increase in RV afterload, secondary to a multifactorial process, might play a role in this phenomenon. In adjunction to general causes involving the right heart similarly to the left chambers, the RV must sustain the additional burden of the respiratory illness due to SARS-CoV-2 infection. Right chambers tolerate preload augmentation worse than their left counterparts. Thus, high RV pressure produces RV myocardial stress and troponin release [69] . Increased levels of NT-ProBNP, the gold-standard biomarker of right and LV stretching in PH and/or heart failure, are commonly observed in COVID-19 patients [43, 47, 58] .

Pulmonary hypertension (PH) is being increasingly reported among patients with COVID-19 [46, 66, 70, 71] . Its development is likely multifactorial and may be related to ventilation perfusion mismatch in the setting of significant hypoxic respiratory failure and acute respiratory distress syndrome, increased pulmonary vascular tone in the setting of inflammatory state, and presence of microthrombi or pulmonary embolism in the lungs [13, 27, 71, 72] .

In standard echocardiography, estimated sPAP is widely used to define the presence of PH, although guidelines recommend using the continuous wave Doppler measurement of peak TRV together with other sign of increased right heart overload as the unique variables for assigning the TTE probability of PH [73, 74] . However, many studies report sPAP as a valid parameter to assess COVID-19 severity, since it appears to be higher in severely ill patients [22, 23, 63] , in subjects with previous cardiovascular diseases [41] , and in those at higher risk of in-hospital mortality [32, 41, 46, 57] . Moreover, a direct correlation has been found between sPAP, D-dimer and troponin [38] . A study stratifying non-intensive care unit (ICU) patients according to presence/absence of PH (defined as sPAP > 35 mmHg) [53] showed that, after adjustments for confounders, PH was the only significative predictive parameter of mortality. According to the authors, the initial hemodynamic alterations caused by SARS-CoV-2 pneumonia may determine only modest sPAP elevation, still not sufficient to induce significant RV dysfunction. However, COVID-19 is thought to alter the ventilation-to-perfusion ratio via a mismatch caused by capillary microthrombosis in some regions of the pulmonary vasculature. Such alterations of the pulmonary circulation may be the primary triggers causing involvement of right heart chambers [13, 75] . Analysing the impact of anticoagulation therapy (prophylactic or full-dose) on PH in patients with COVID-19 is cumbersome, since the majority of patients in the reported studies received anticoagulation [51] . Assessing whether echocardiography-directed use of higher doses of anticoagulation in these patients will reduce the rates of RV dysfunction and improve prognosis requires larger prospective studies [58] .

The prognostic value of PH in the ICU setting was investigated in a study enrolling mainly intubated patients, where a sPAP > 35 mmHg increased the risk of in-hospital mortality after correction for confounders [34] . The incidence of PH varied among group of patients stratified by Pa O2 /Fi O2 . This suggests a different relationship in severe COVID-19 among RV preload and respiratory mechanics and might be partly caused by IMV. Positive end expiratory pressure causes an increase in pulmonary West zones 1 and 2 at the expense of zones 2 and 3, thus increasing pulmonary vascular resistance. Respiratory failure in COVID-19 leads to a large use of continuous positive airways pressure (C-PAP) and intubation: both cause important changes in thoracic pressures and thus in ventricular afterload [76, 77] .

Finally, PH may represent a possible long-term complication of COVID-19. Tudoran et al. [59] performed TTE two months after discharge in patients that experienced mild/moderate pneumonia. They found 7 patients on a sample of 91 (8%) with PH, and 11 subjects (20%) with sPAP > 30 mmHg but < 35 mmHg. This prevalence of PH is higher compared to the general population [78] . Other studies found elevated sPAP and PH as a common COVID-19 complication [39, 52] , highlighting the need to further investigate long-term sequalae involving the RV after SARS-CoV-2 infection.

Right ventricular longitudinal strain (RVLS) is obtained from the apical four-chamber view, and it reflects the average value of the RV free wall and septal segments or of the RV free wall strain alone [79] . A meta-analysis suggested − 27 ± 2% as the normal range [80] , but an RVLS cutoff of − 20% to − 21% seems to be able to detect abnormal RV function [81] . RVLS calculated by two-dimensional speckle tracking echocardiography (2D-STE) proved to be a reliable and accurate tool for the evaluation of RV systolic function when validated against RVEF by CMR in several clinical settings, including PH, pulmonary embolism, heart failure, myocardial infarction, cardiomyopathies, and valvular heart diseases [79, [82] [83] [84] . Moreover, impaired RVLS was associated with poor prognosis in inferior myocardial infarction [85] , functional tricuspid regurgitation [86] , and heart failure with preserved ejection fraction [87] .

Currently, 2D-STE is not part of a standard TTE study, since it needs more time than a normal TTE exam and higher expertise, which explains the exiguity of studies reporting RV 2D-STE measurements in COVID-19. However, several works defend the advantages achieved through 2D-STE in RV functional evaluation.

RVLS appears to be reduced in COVID-19 if compared to controls [44] or to reference values [28] in two studies in which the percentage of intubated patients were respectively 0% and 15%. Furthermore, similar evidence has been reported in studies describing the follow up of survivors [39, 52] , where patients who experienced more severe pneumonia characterized by a more reliable decrease of RVLS.

Evidence of worse values of RVLS in patients with acute cor pulmonale, 62 [24] severe COVID-19 21 [23] and in nonsurvivors [28, 46] has been reported. Predictive capacity of RVLS for all-cause-mortality has been demonstrated [23, 28, 46] . Among the studies presenting this evidence, the observational cross-sectional single-center cohort study by Li et al . [46] operated a stratification based on RVLS distribution by tertiles of 120 patients, 12.5% of whom were intubated. They identified higher values of D-dimer and C-Reactive Protein and higher frequency of high-flow-oxygen therapy and IMV in the less negative RVLS group. Furthermore, in the analysis of RVLS predictiveness the authors identified the cut-off value of 23% for recognizing the risk of mortality, with a sensitivity of 94.4% and specificity of 64.7%. The independence of RVLS predictivity from LV parameters and the importance of RV strain to evaluate the severity of illness were presented as the major finding of the study. The authors operated a comparison with the conventional measurements of RV function, describing TAPSE and S′ only as a partial representation of the RV contraction (since these define only RV free wall basal segment), and RVFAC having a great interobserver and intraobserver variability because of its dependence from imaging plane. The conclusions in terms of clinical utility of TTE were similar to Lassen et al. [44] , suggesting TTE evaluation of RVLS as an important prognostic tool in patient stratification. Moreover, 2D-STE was independent from associated myocardial injury, as no significant difference was reported in troponin values levels among tertiles of RVLS.

The results of this systematic review suggest that:

• RV size is larger in patients with more severe illness, and RV dilatation is a cardiac abnormality more frequent than LV or RV functional decline. • Alteration of TAPSE, S' and RVFAC are frequent in patients with COVID-19 and are predictors of mortality, but relative preservation of longitudinal shortening in RV dysfunction indicate RVFAC as a more appropriate measure of global RV function. • Elevated sPAP is present in COVID-19 and appears to be useful in early disease and in patients undergoing IMV. Furthermore, PH may play a role as a long-term complication. • RVLS might be superior to 2-dimensional measurements to evaluate ventricular loss of function and predict adverse outcomes. • Given the first evidence of long-term RV involvement after COVID-19, echocardiographic follow-up could be useful to stratify patients at higher risk of complications. Table 2 summarizes the main evidence of the most used TTE parameters in RV assessment in COVID-19.

According to recommendations for right heart assessment, patients with COVID-19 should undergo echocardiography focused on the RV in order to exclude or confirm a right ventricular failure or overload, precise prognosis, stratify prognosis and optimize treatment [88] .

In COVID-19, standard 4-chamber view can provide an accurate morphological and functional quantification of the right heart. However, RV size and function parameters measured from the RV-focused view are more reproducible than from 4-chamber acquisitions. Therefore, when clinical conditions allow the optimal acquisition of echocardiographic images, only the RV-focused view should be used for quantitative assessment of the RV [89] . 

RV contractility can be assessed through TAPSE, S', RVFAC and RVLS. TAPSE and S' can be regularly obtained in standard 4 chambers view and provide a reliable quantification of systolic function. The two latter normally need an optimal RV-focused view to be accurate. Compared to RVFAC, RV-strain is an advanced technique that is relatively angle-independent and possesses an improved signal-to-noise ratio. RVLS is still lacking normative data and requires additional validation. However, once a RV-focused view is available, RVLS provides a reliable global systolic functional assessment [90] .

Patients with COVID-19 may develop pulmonary circulation disarrangement driven by vasoconstriction, pulmonary angiopathy, in-situ thrombosis, pulmonary embolisms, severe hypoxemia, and left heart dysfunction [91, 92] . An accurate echocardiography assessment of cardiopulmonary hemodynamics may guide the optimal treatment strategy beside providing a prognostic stratification.

Estimation of sPAP can result inaccurate in COVID-19 patients supported with non-invasive or IMV, since positive end-expiratory pressure influences RAP, which is added to right atrial-ventricular gradient obtained from tricuspid regurgitant jet velocity to calculate sPAP [27] . Table 3 summarizes the main parameters of echocardiographic RV assessment, their clinical meaning and technical feasibility.

Some limitations should be considered when comparing the presented reports.

First, the majority of the studies included in the analysis are single center retrospective studies, with a small sample size. Hence, there is scarce homogeneity in all TTE examinations in terms of timing and choice of parameters. Second, the rate of TTE abnormalities in most studies cannot be considered representative of the population, as retrospective observational analyses only consider patients undergoing TTE to answer clinical questions, and even cross-sectional or prospective studies are not able to evaluate infected people not referring to the hospital. Third, many authors report difficulties in the execution of TTE exams, given the clinical risk of infection for examiners, the reduced quality of acoustic windows, along with the inability of patients to breathhold and position in the recombinant position. Thus, it may have influenced even the quality of the measurements and therefore could be considered a potential bias.

As the pandemic has been present for one year only, longterm sequelae regarding RV involvement or the development of cardiac dysfunction and/or heart failure are yet unknown and deserve further investigation. The findings presented in this review might be used to establish a TTE protocol to stratify patients and to early detect cardiac dysfunction that may need more focused care.

RV involvement is a frequent issue in COVID-19 and its features vary with the progression of illness. The pathogenesis of right heart damage is multifactorial and may be influenced by IMV. Echocardiographic assessment of the RV can be useful to stratify patients, to characterize myocardial injury, and to guide management in severe illness. Table 3 Overview of the clinical meaning and technical feasibility of commonly used parameters of right ventricular assessment in echocardiography. Modified from Rudski et al. [90] , Galiè et al. [73] and Lang et al. [65] RAP right atrial pressure, RVFAC right ventricle fractional area change, RVEDD right ventricular end diastolic diameter, RVLS right ventricular global longitudinal strain, S' tricuspid lateral annular systolic velocity, sPAP systolic pulmonary artery pressure, TAPSE tricuspid annular plane systolic excursion, TR tricuspidal regurgitation 

Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan

Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)

Elevated troponin in patients with coronavirus disease 2019: possible mechanisms

Emerging evidence of myocardial injury in COVID-19: a path through the smoke

Cardiac injury is associated with severe outcome and death in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies

Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19

Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study

Prognostic parameters of in-hospital mortality in COVID-19 patients-an Italian experience

Right ventricular dilation in hospitalized patients with COVID-19 infection

Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging

Echocardiographic features of COVID-19 illness and association with cardiac biomarkers

Echocardiographic findings in patients with COVID-19 pneumonia

Pulmonary angiopathy in severe COVID-19: physiologic, imaging, and hematologic observations

Acute cor pulmonale in ARDS: rationale for protecting the right ventricle

Natriuretic peptides, respiratory disease, and the right heart

BNP in septic patients without systolic myocardial dysfunction

COVID-19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel

ASE statement on protection of patients and echocardiography service providers during the 2019 novel coronavirus outbreak: endorsed by the American College of Cardiology

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

Incidence and determinants of high-sensitivity troponin and natriuretic peptides elevation at admission in hospitalized COVID-19 pneumonia patients

Advanced echocardiographic phenotyping of critically ill patients with coronavirus-19 sepsis: a prospective cohort study

Echocardiographic features of patients with COVID-19 infection: a cross-sectional study

Evaluation of biventricular function in patients with COVID-19 using speckle tracking echocardiography

Usefulness of right ventricular longitudinal shortening fraction to detect right ventricular dysfunction in acute cor pulmonale related to COVID-19

Left and right ventricular dysfunction in patients with COVID-19-associated myocardial injury

Point-of-care ultrasound for COVID-19 pneumonia patients in the ICU

Right ventricular dysfunction in critically ill COVID-19 ARDS

Prognostic utility of quantitative offline 2D-echocardiography in hospitalized patients with COVID-19 disease

Non-invasive hemodynamic profile of early COVID-19 infection

Reduced cardiac function is associated with cardiac injury and mortality risk in hospitalized COVID -19 patients

Prospective multicentre cohort study of transthoracic echocardiography provision in the South West of the UK during the first wave of SARS-CoV-2 pandemic

Right ventricular-arterial uncoupling independently predicts survival in COVID-19 ARDS

Characteristics of cardiac injury in critically Ill patients with coronavirus disease

Critical care ultrasonography during COVID-19 pandemic: the ORACLE protocol

Transthoracic echocardiography during prone position ventilation: lessons from the COVID-19 pandemic

Right ventricular strain is common in intubated COVID-19 patients and does not reflect severity of respiratory illness

Characterization of myocardial injury in patients with COVID-19

Predictive factor for COVID-19 worsening: insights for high-sensitivity troponin and D-dimer and correlation with right ventricular afterload

The effect of moderate and severe COVID-19 pneumonia on short-term right ventricular functions: a prospective observational single pandemic center analysis

Indications for and findings on transthoracic echocardiography in COVID-19

Comprehensive echocardiographic findings in critically Ill COVID-19 patients with or without prior cardiac disease

Cardiac manifestations of coronavirus disease 2019 (COVID-19): a multicenter cohort study

Prognostic utility of right ventricular remodeling over conventional risk stratification in patients with COVID-19

Echocardiographic abnormalities and predictors of mortality in hospitalized COVID-19 patients: the ECHOVID-19 study

Acute right ventricular dysfunction in severe COVID-19 pneumonia

Prognostic value of right ventricular longitudinal strain in patients with COVID-19

Echocardiographic characteristics and outcome in patients with COVID-19 infection and underlying cardiovascular disease

Swollen heart in COVID-19 patients who progress to critical illness: a perspective from echocardiologists

Echocardiographic findings in patients with COVID-19 pneumonia

Impact of right ventricular dysfunction on mortality in patients hospitalized with COVID-19 according to race

Acute pulmonary hypertension and short-term outcomes in severe Covid-19 patients needing intensive care

Impairment of right ventricular longitudinal strain associated with severity of pneumonia in patients recovered from COVID-19

Integrated clinical role of echocardiography in patients with COVID-19

Impaired cardiac function is associated with mortality in patients with acute COVID-19 infection

Transthoracic echocardiographic findings in patients admitted with SARS-CoV-2 infection

Left ventricular global longitudinal strain in identifying subclinical myocardial dysfunction among patients hospitalized with COVID-19

A pilot study on right ventricular longitudinal strain as a predictor of outcome in COVID-19 patients with evidence of cardiac involvement

Spectrum of cardiac manifestations in COVID-19

Evidence of pulmonary hypertension after SARS-CoV-2 infection in subjects without previous significant cardiovascular pathology

The utility of bedside echocardiography in critically ill COVID-19 patients: early observational findings from three Northern New Jersey hospitals

Biventricular longitudinal strain predict mortality in COVID-19 patients

Cardiac manifestations of COVID-19 in Shenzhen

Prognostic value of right ventricular ejection fraction assessed by 3D echocardiography in COVID-19 patients

Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

Suspected myocardial injury in patients with COVID-19: evidence from front-line clinical observation in Wuhan, China

The overloaded right heart and ventricular interdependence

COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis? Heart

ST-elevation myocardial infarction in patients with COVID-19: clinical and angiographic outcomes

An update on pulmonary hypertension in coronavirus disease-19 (COVID-19): pulmonary Hypertension and COVID -19

Association of right ventricular dysfunction and pulmonary hypertension with adverse 30-day outcomes in COVID-19 patients

Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19

ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

Textbook of clinical echocardiography, 6th edn

COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal

Complications of mechanical ventilation and positive end-expiratory pressure

Cyclic changes in right ventricular output impedance during mechanical ventilation

Prevalence of pulmonary hypertension in the general population: the Rotterdam Study

Role of two-dimensional speckle-tracking echocardiography strain in the assessment of right ventricular systolic function and comparison with conventional parameters

Reference values for right ventricular strain in patients without cardiopulmonary disease: a prospective evaluation and meta-analysis

Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

Comparison of novel echocardiographic parameters of right ventricular function with ejection fraction by cardiac magnetic resonance

Quantitative analysis of right ventricular (RV) Function with echocardiography in chronic heart failure with no or mild RV dysfunction: comparison with cardiac magnetic resonance imaging

Traditional and innovative echocardiographic parameters for the analysis of right ventricular performance in comparison with cardiac magnetic resonance

Impaired RV global longitudinal strain is associated with poor long-term clinical outcomes in patients with acute inferior STEMI

Prognostic implications of right ventricular free wall longitudinal strain in patients with significant functional tricuspid regurgitation

Right ventricular global longitudinal strain and outcomes in heart failure with preserved ejection fraction

Chinese Critical Care Ultrasound Study Group (CCUSG) (2020) Using echocardiography to guide the treatment of novel coronavirus pneumonia

Comparison between four-chamber and right ventricular-focused views for the quantitative evaluation of right ventricular size and function

Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography

Extrapulmonary manifestations of COVID-19

Coronavirus and cardiovascular disease, myocardial injury, and arrhythmia: JACC focus seminar

Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations